Multiple Assemblies exist for SMTL entry 3iu3
Crystal structure of the Fab fragment of therapeutic antibody Basiliximab in complex with IL-2Ra (CD25) ectodomain; X-RAY DIFFRACTION 2.90 Å

	SMTL ID 3iu3.1 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Heavy chain of Fab fragment of Basiliximab; Light chain of Fab fragment of Basiliximab; Interleukin-2 receptor alpha chain Oligo-state hetero-1-1-1-mer
	SMTL ID 3iu3.2 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Heavy chain of Fab fragment of Basiliximab; Light chain of Fab fragment of Basiliximab; Interleukin-2 receptor alpha chain Oligo-state hetero-1-1-1-mer
	SMTL ID 3iu3.3 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Heavy chain of Fab fragment of Basiliximab; Light chain of Fab fragment of Basiliximab; Interleukin-2 receptor alpha chain Oligo-state hetero-1-1-1-mer